These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2428787)

  • 1. Thyroid lymphomas stages IE and IIE: comparative results for radiotherapy only, combination chemotherapy only, and multimodality treatment.
    Vigliotti A; Kong JS; Fuller LM; Velasquez WS
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1807-12. PubMed ID: 2428787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stages IE and IIE non-Hodgkin's lymphomas of the stomach. Comparison of treatment modalities.
    Maor MH; Maddux B; Osborne BM; Fuller LM; Sullivan JA; Nelson RS; Martin RG; Libshitz HI; Velasquez WS; Bennett RW
    Cancer; 1984 Dec; 54(11):2330-7. PubMed ID: 6208989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome analysis for stage IE and IIE thyroid lymphoma.
    DiBiase SJ; Grigsby PW; Guo C; Lin HS; Wasserman TH
    Am J Clin Oncol; 2004 Apr; 27(2):178-84. PubMed ID: 15057158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma.
    Maor MH; Velasquez WS; Fuller LM; Silvermintz KB
    J Clin Oncol; 1990 Feb; 8(2):266-71. PubMed ID: 1688927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined modality therapy in Stage III and Stage IIIE diffuse large cell lymphomas.
    Velasquez W; Fuller LM; Oh KK; Hagemeister FB; Sullivan JA; Manning JT; Shullenberger CC
    Cancer; 1984 Apr; 53(7):1478-83. PubMed ID: 6199100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies.
    Green LD; Mack L; Pasieka JL
    J Surg Oncol; 2006 Dec; 94(8):725-36. PubMed ID: 17131397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
    Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF
    Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma.
    Wilder RB; Rodriguez MA; Ha CS; Pro B; Hess MA; Cabanillas F; Cox JD
    Cancer; 2001 Jun; 91(12):2440-6. PubMed ID: 11413536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs.
    Salles G; Herbrecht R; Tilly H; Berger F; Brousse N; Gisselbrecht C; Coiffier B
    Am J Med; 1991 Jan; 90(1):77-84. PubMed ID: 1702581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I-II low-grade lymphomas: a prospective trial of combination chemotherapy and radiotherapy.
    McLaughlin P; Fuller L; Redman J; Hagemeister F; Durr E; Allen P; Holmes L; Velasquez W; Swan F; Cabanillas F
    Ann Oncol; 1991 Feb; 2 Suppl 2():137-40. PubMed ID: 1710918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
    Schlembach PJ; Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1107-10. PubMed ID: 11072169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.
    Bajetta E; Valagussa P; Bonadonna G; Lattuada A; Buzzoni R; Rilke F; Banfi A
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):3-12. PubMed ID: 2455701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric lymphomas: chemotherapy as a primary treatment.
    Solidoro A; Payet C; Sanchez-Lihon J; Montalbetti JA
    Semin Surg Oncol; 1990; 6(4):218-25. PubMed ID: 1697094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy.
    Jones SE; Miller TP; Connors JM
    J Clin Oncol; 1989 Sep; 7(9):1186-91. PubMed ID: 2671279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
    Reyes F; Lepage E; Ganem G; Molina TJ; Brice P; Coiffier B; Morel P; Ferme C; Bosly A; Lederlin P; Laurent G; Tilly H;
    N Engl J Med; 2005 Mar; 352(12):1197-205. PubMed ID: 15788496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid lymphoma. The case for combined modality therapy.
    Doria R; Jekel JF; Cooper DL
    Cancer; 1994 Jan; 73(1):200-6. PubMed ID: 8275426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
    Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J
    Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in non-Hodgkin's lymphoma.
    Tubiana M; Carde P; Burgers JM; Cosset JM; Van Glabbeke M; Somers R
    Int J Radiat Oncol Biol Phys; 1986 Apr; 12(4):503-14. PubMed ID: 3516950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.